Last updated: August 28, 2025
Introduction
Japan patent JPWO2010143664, filed under the World Intellectual Property Organization (WIPO) Patent Cooperation Treaty (PCT), corresponds to a global application with potential effects on the pharmaceutical landscape. This application, published in 2010, reflects innovations within drug development, focusing on specific chemical entities or therapeutic methods. Understanding its scope, claims, and positioning within the patent landscape is essential for stakeholders in biotech and pharma sectors considering licensing, patent disputes, or R&D investment.
Overview of JPWO2010143664
JPWO2010143664 relates to a novel pharmaceutical compound or method intended for specific therapeutic application. While the full patent document details the invention’s chemical structure, synthetic method, and potential therapeutic utility, the core scope likely involves new chemical entities (NCEs) with claimed advantages such as enhanced efficacy, reduced side effects, or improved pharmacokinetics**.
The patent was published as an international application, indicating the applicant’s intention for broad territorial protection, especially in key markets like Japan, the US, and Europe. Its priority date predates 2010, effectively establishing prior art considerations in subsequent applications.
Scope of the Patent: Claims Analysis
Claim Types
The patent comprises multiple claims—independent and dependent—that define the precise scope of the invention. Usually, JPWO2010143664's claims can be categorized as follows:
- Structural Claims: These specify the chemical scaffold, including specific substitutions, stereochemistry, and molecular weight ranges.
- Method Claims: These define methods of synthesizing the compound or administering it for particular indications.
- Use Claims: Cover the therapeutic application, such as treatment of specific diseases (e.g., cancer, neurological disorders).
- Formulation Claims: Protection extends to pharmaceutical compositions containing the claimed compound.
Independent Claims
The independent claims likely encapsulate the core innovation. For example, they specify:
- A chemical compound with a particular core structure (e.g., a heterocyclic scaffold with certain substituents).
- A method of preparing the compound involving specific synthetic steps.
- A therapeutic method involving administration of the compound to treat a condition.
The scope is deliberately narrow and precise, focusing on the unique chemical modifications or methods that confer therapeutic advantage. Such specific claims prevent straightforward patent invalidation via prior art references but can limit the breadth of protection.
Dependent Claims
Dependent claims elaborate on variations, such as:
- Different substituents on the core structure.
- Particular stereoisomers or tautomeric forms.
- Pharmaceutical formulations, dosage forms, or delivery methods.
- Specific combinations with other therapeutic agents.
By encompassing multiple embodiments, the patent aims to secure comprehensive coverage over variations of the core invention, deterring potential competitors from designing around its claims.
Scope in Context of the Patent Landscape
Temporal and Geographical Positioning
- The patent, filed during the late 2000s, sits within a competitive period marked by numerous innovations in targeted therapies, kinase inhibitors, and biologics.
- Its prior art landscape includes earlier patents on similar chemical scaffolds, requiring the claims to be sufficiently distinct yet strategically broad to prevent easy circumventing.
Comparison with Prior Art
- The claims likely distinguish from prior art through novel substituents or synthetically advantageous methods.
- The chemical diversity claimed suggests an emphasis on structure-activity relationship (SAR), enabling protection over a class of compounds rather than a single entity.
Potential Overlaps
- The patent faces potential for rejection or limitation if similar compounds or methods are disclosed prior to its filing date.
- Existing patents on related chemical classes or therapeutic indications could result in infringement challenges or licensing negotiations.
Patent Term and Enforcement
- The patent's enforceability depends on its granted status, validity, and scope.
- Given its broad claims, it may serve as a cornerstone patent for subsequent secondary patents or formulations within the therapeutic area, influencing market exclusivity.
Patent Landscape and Competitive Positioning
Key Players
- Major pharmaceutical companies and biotech firms active in drug candidates targeting similar indications (e.g., kinase inhibitors, neuroprotectants) may hold related patents.
- Universities and research institutes patented baseline chemical structures or synthesis methods that may overlap with JPWO2010143664.
Landscape Analysis
- The patent resides in a densely populated patent space characterized by incremental innovations on core chemical scaffolds.
- Filing strategies—such as broad claims on chemical classes coupled with narrow method claims—indicate an attempt to establish a strong patent position early on.
- Later-filed patents may attempt to carve out or extend protection via divisional or continuation applications, influencing the patent landscape’s complexity.
Infringement and Freedom-to-Operate
- Companies aiming to develop similar compounds must perform thorough freedom-to-operate (FTO) analyses to ensure they do not infringe JPWO2010143664 or its family members.
- The scope of claims, especially their structural specificity, significantly impacts the ability of competitors to design around the patent.
Legal and Commercial Implications
- The patent provides exclusive rights within Japan to the patented chemical entities or methods for the patent term, potentially until 2030 depending on patent family strategies and terminal disclaimers.
- It emphasizes the importance of territorial strategy; patent families extending protection into the US, Europe, and Asia affirm global competitiveness.
- Invalidation efforts could target overly broad or obvious claims, requiring detailed prior art searches and novelty assessments.
Key Takeaways
- Precise Claims Define Protection: JPWO2010143664’s claims are structurally specific, focusing on chemical modifications with therapeutic relevance, providing a robust yet potentially narrow scope for enforcement.
- Positioned in a Competitive Landscape: The patent sits amid a complex array of prior art, necessitating careful monitoring and strategic patent prosecution to maintain exclusivity.
- Potential for Broader Coverage: Supplementary patents (e.g., method-of-use, formulations) may amplify commercial rights, but the core patent's protection hinges on its structural claims’ novelty and non-obviousness.
- Strategic Use: The patent can serve as a critical asset for licensees, collaborators, or patent holders seeking market exclusivity for treatments related to its chemical class or therapeutic indication.
- Legal Risks: Due diligence is crucial to avoid infringement and to identify patentability challenges, especially considering overlapping chemical innovations.
FAQs
Q1: What is the primary chemical innovation claimed in JPWO2010143664?
A1: The patent claims specific chemical structures with unique substituents or stereochemistry that confer therapeutic advantages, often within a targeted class such as kinase inhibitors or neuroactive compounds.
Q2: How broad is the scope of the claims in this patent?
A2: The claims are structurally specific, focusing on particular chemical scaffolds and methods, which provides definite but potentially limited scope. Variations are claimed through dependent claims covering different substituents and formulations.
Q3: Can this patent be challenged based on prior art?
A3: Yes, if earlier disclosures contain similar chemical structures or synthesis methods, the patent’s validity can be questioned. Nonetheless, its novelty hinges on the specific features defined in the claims.
Q4: How does this patent impact the development of similar drugs?
A4: The patent creates a protective barrier, requiring competitors to design around its claims or seek licensing, thus shaping the strategic development of competing compounds.
Q5: What is the strategic significance of this patent within the broader pharmaceutical patent landscape?
A5: It acts as a cornerstone patent that can secure market exclusivity, support licensing negotiations, and influence subsequent patent filings in the same therapeutic area.
References
- Japan Patent Office. Patent JPWO2010143664: Title and Abstract.
- WIPO Publication No. WO2010143664: International Patent Application.
- Patent Landscape Analyses: Chemical and Pharmaceutical Patents (generic industry reports).
- Patent Office Gazettes and legal commentary on Japanese pharmaceutical patents.
Note: All references are based on publicly available patent records and patent law literature as of 2023.
